CRP and type 2 diabetes mellitus: Gutierrez et al. showed that in 60 patients with type 2 diabetes, BA (80 mg once daily for 2 weeks, followed by 120 mg once daily for 2 more weeks) lowered LDL-C and high-sensitivity C-reactive protein (hs-CRP) (−43% and −41%, respectively) compared with placebo (−4% and −11%) [31].